3 Things In Biotech You Should Learn Today: May 27, 2017 – Seeking Alpha
|
3 Things In Biotech You Should Learn Today: May 27, 2017
Seeking Alpha CAR–T cell therapy is reaching its tipping point, and we're going to find out in 2017 if these agents are deemed to have a risk/benefit profile that is sufficient for the FDA to allow their use. Kite Pharma (NASDAQ:KITE) made a splash when they … |
